Summit Therapeutics PLC (LSE:SUMM) - Share price


Stock Report

Summit Therapeutics PLC SUMM

Last Price
GBX22.30

Day Change
-0.70|-3.04%

As of 17/10/2019
09:59:34 BST | GBX
Minimum 15 Minutes Delay.

Last Close23.00p
Day Range22.30 - 22.30
Mkt Cap44.94Mil
52-Wk Range9.50 - 34.67
Yield %-
ISINGB00BN40HZ01
Volume1,918
P/E1.81
P/S0.00
P/CF-0.01

Share Price

Total Returns 16/10/2019

 Chg (%)  
More ...
Summit Therapeutics PLC4.55 
FTSE 100 TR GBP-1.86
 
Financials
201720182019
More ...
Income Statement
Turnover2.3012.3643.01
Operating Profit-24.32-23.866.96
Net Profit-21.37-20.197.53
Reported EPS-35.00-31.009.00
Balance Sheet
Current Assets33.3435.8946.73
Non Current Assets4.2518.0713.03
Total Assets37.5953.9659.77
Current Liabilities10.9022.7712.87
Total Liabilities---
Total Equity-3.49-3.1842.54
Cash Flow
Operating Cash Flow9.14-18.06-26.95
Net Change in Cash12.47-6.036.33

Company Profile

Summit Therapeutics PLC is a biopharmaceutical company focused on the discovery, development and commercialization of novel medicines for indications for which there are no existing or only inadequate therapies.

Sector

Drug Manufacturers - Specialty & Generic

Index

FTSE AIM All-Share

Next Event 11/10/2019

Half-Yearly Results
Ratios
Comp
More ...
PER (E)1.54
Div Yld (E)0.00
PEG (E)0.00
ROCE14.84
Op Mrgn0.16
EPS Grwth0.00
Dividends
PreviousLatest
More ...
Record Datet.b.c.t.b.c.
Ex-Divt.b.c.t.b.c.
Paidt.b.c.t.b.c.
Amnt0.000.00
Directors
More ...
Non-Executive DirectorMr. David M. Wurzer
Non-Executive DirectorMs. Valerie L. Andrews
Non-Executive DirectorDr. Barry John Price
Executive Director, Chief Executive OfficerMr. Glyn Owain Edwards MBE
Non-Executive Director, ChairmanDr. Frank Murdoch Armstrong
Non-Executive DirectorMr. Leopoldo Giampaolo Zambeletti
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2019 Morningstar. All rights reserved.